Detection of MUM1/IRF4-IgH fusion in multiple myeloma

被引:56
|
作者
Yoshida, S
Nakazawa, N
Iida, S
Hayami, Y
Sato, S
Wakita, A
Shimizu, S
Taniwaki, M
Ueda, R
机构
[1] Nagoya City Univ, Sch Med, Dept Internal Med 2, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Kyoto Prefectural Univ Med, Dept Internal Med 3, Kyoto 602, Japan
[3] Shimane Prefectural Cent Hosp, Izumo, Shimane, Japan
关键词
MUM1/IRF4; multiple myeloma; t(6; 14)(p25; q32); IgH insertion; FISH; PFGE;
D O I
10.1038/sj.leu.2401563
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MUM1 (multiple myeloma oncogene 1)/IRF4 (interferon regulatory factor 4) gene has been identified as an oncogene transcriptionally activated by t(6;14)(p25;q32) chromosomal translocation in multiple myeloma (MFA). The significance of this alteration in MM remains unknown, as it is not detectable by means of conventional cytogenetic analysis. To address this issue, we established diagnostic procedures based on pulsed-field gel electrophoresis (PFGE) analysis and double color fluorescence in site hybridization (DCFISH) using DNA probes derived from the MUM1 and the immunoglobulin heavy chain (IgH) gene loci. Among a panel of 17 MM cell lines, three (17.6%) showed fusions between these two loci, which resulted in the juxtaposition of the MUM1 to the IgH 3' alpha-enhancer region by virtue of t(6;14) or insertion of the IgH sequences into the vicinity of the MUM1 gene and in the concomitant overexpression of the MUM1 mRNA. With similar results, fusions between MUM1 and IgH loci were observed by means of interphase DCFISH in eight (21.1%) out of the 38 MM cases, although no definite relationships between MUM1 status and specific clinical findings could be established.
引用
收藏
页码:1812 / 1816
页数:5
相关论文
共 50 条
  • [1] Detection of MUM1/IRF4-IgH fusion in multiple myeloma
    S Yoshida
    N Nakazawa
    S Iida
    Y Hayami
    S Sato
    A Wakita
    S Shimizu
    M Taniwaki
    R Ueda
    Leukemia, 1999, 13 : 1812 - 1816
  • [2] Detection of MUM1/IRF4 rearrangement in multiple myeloma.
    Iida, S
    Nakazawa, N
    Yoshida, S
    Hayami, Y
    Sato, S
    Wakita, A
    Shimizu, S
    Taniwaki, M
    Ueda, R
    BLOOD, 1998, 92 (10) : 715A - 715A
  • [3] Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
    Iida, S
    Rao, PH
    Butler, M
    Corradini, P
    Boccadoro, M
    Klein, B
    Chaganti, RSK
    DallaFavera, R
    NATURE GENETICS, 1997, 17 (02) : 226 - 230
  • [4] Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
    Shinsuke Iida
    Pulivarthi H. Rao
    Marion Butler
    Paolo Corradini
    Mario Boccadoro
    Bernard Klein
    R.S.K. Chaganti
    Riccardo Dalla-Favera
    Nature Genetics, 1997, 17 : 226 - 230
  • [5] Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma
    Heintel, D.
    Zojer, N.
    Schreder, M.
    Strasser-Weippl, K.
    Kainz, B.
    Vesely, M.
    Gisslinger, H.
    Drach, J.
    Gaiger, A.
    Jaeger, U.
    Ludwig, H.
    LEUKEMIA, 2008, 22 (02) : 441 - 445
  • [6] Lenalidomide Inhibits the Multiple Myeloma Cell Survival Factor IRF4/MUM1
    Lopez-Girona, A.
    Mendy, D.
    Gaidarova, S.
    Brady, H.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S122 - S122
  • [7] Expression of MUM1/IRF4 mRNA as a prognostic marker in patients with multiple myeloma
    D Heintel
    N Zojer
    M Schreder
    K Strasser-Weippl
    B Kainz
    M Vesely
    H Gisslinger
    J Drach
    A Gaiger
    U Jäger
    H Ludwig
    Leukemia, 2008, 22 : 441 - 445
  • [8] Lenalidomide inhibits the multiple myeloma cell-survival factor IRF4/MUM1
    Lopez-Girona, Antonia
    Mendy, Derek
    Brady, Helen
    Gaidarova, Svetlana
    CANCER RESEARCH, 2009, 69
  • [9] MUM1/IRF4 A Review
    Gualco, Gabriela
    Weiss, Lawrence M.
    Bacchi, Carlos E.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2010, 18 (04) : 301 - 310
  • [10] High expression of MUM1/IRF4 mRNA is associated with a shorter overall survival in patients with multiple myeloma.
    Heintel, D
    Zojer, N
    Strasser-Weippl, K
    Vesely, M
    Gisslinger, H
    Drach, J
    Gaiger, A
    Jäger, U
    Ludwig, H
    BLOOD, 2005, 106 (11) : 445A - 445A